Heart Rate Control With Esmolol in Septic Shock

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

Also called NCT01231698

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 154 participants (enrolled count) (from the registry)
Sponsor
Andrea Morelli (from the registry)
Registry
  • NCT NCT01231698
Other papers using this trial's data
  • Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial JAMA, 2013-10-23 DOI, PubMed 24108526

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01231698. Randomized; no masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2012-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Heart Rate Control With Esmolol in Septic Shock
Condition
Septic Shock
Intervention (Drug)
esmolol
Intervention (Other)
control
Lead sponsor
Andrea Morelli (class: other)

Record details

Record id
cardio:ct-nct01231698
Content hash
4db0df9d6572906d1a6ee265393062735e18a195091fab0f048b44ad485b5ade